Literature DB >> 27515715

Antiviral Medication in Sexually Transmitted Diseases. Part III: Hepatitis B, Hepatitis C.

Anna Majewska, Beata Mlynarczyk-Bonikowska1, Magdalena Malejczyk, Slawomir Majewski, Grazyna Mlynarczyk.   

Abstract

In the previous parts of the series the antiviral agents used in genital herpes, genital HPV infection and therapeutic options in HIV infections were presented. The sexual contact is one of the major routes in the transmission of HBV and also possible modes of transmission of HCV. In this review we present the clinical indications, mechanisms of action, and side effects of presently available medication for the management of HBV and HCV infections. Currently a revolution is happening in the therapy of chronic hepatitis, especially caused by HCV. Direct-acting antivirals promise to open a new era in treating of chronic HCV infection. Efficacious, simplified and well tolerated interferon-free, and in some cases ribavirin-free regiments are available already and several other inhibitors currently are in the clinical trials.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27515715     DOI: 10.2174/1389557516666160808114408

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  2 in total

1.  Sero-Prevalence of HBV and its Associated Factors Among Healthcare Providers in Public Health Facilities in Eastern Ethiopia.

Authors:  Degu Abate; Abebe Tolera; Behailu Hawulte; Tewodros Tesfa; Ayele Geleto
Journal:  Infect Dis (Auckl)       Date:  2022-01-08

Review 2.  Lymphogranuloma venereum: an emerging problem in Poland.

Authors:  Katarzyna Smolarczyk; Beata Mlynarczyk-Bonikowska; Slawomir Majewski; Ewa Rudnicka; Magnus Unemo; Piotr Fiedor
Journal:  Postepy Dermatol Alergol       Date:  2020-12-09       Impact factor: 1.664

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.